EpiCept receives another Nasdaq notice
-
- April
- 21
EpiCept Corp., an Eastview company that develops treatments for pain and cancer, has been notified by Nasdaq that it is out of compliance with listing requirements because its stock price closed below $1 a share for 30 straight days. The company now has 180 days, or until Oct. 13, to regain compliance with the rule by seeing that its stock closes at $1 a share or higher for at least 10 straight days.
This entry was posted
on Monday, April 21st, 2008 at 11:04 am by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
Advertisement
